{
    "clinical_study": {
        "@rank": "147856", 
        "arm_group": [
            {
                "arm_group_label": "Cauliflower Mushroom extract", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators performed a 12-week, randomized, double-blind, placebo-controlled human\n      trial to evaluate the efficacy and safety of Cauliflower Mushroom extract on promotion of\n      immunity. The investigators measured promotion of immunity parameters , including\n      Cytotoxicity, Cytokine (IL-4, IL-10, IFN- \u03b3, TNF-\u03b1), and CBC (WBC, RBC, Hb, Hct, MCV, MCH,\n      MCHC, PLT), and monitored their blood pressure."
        }, 
        "brief_title": "Efficacy and Safety of Cauliflower Mushroom Extract on Promotion of Immunity", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "condition": "Immunity", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males and females 30-65 years old\n\n          -  Weight within \u00b130% of ideal body weight\n\n          -  Able to give informed consent\n\n        Exclusion Criteria:\n\n          -  WBC concentration below 3000 \u3395\n\n          -  Allergic or hypersensitive to any of the ingredients in the test products\n\n          -  Diagnosed of gastrointestinal disease such as Immune-related diseases, severe\n             hepatic, renal failure, and diabetes\n\n          -  History of reaction to any of the test products or of gastrointestinal diseases such\n             as Crohn's disease or gastrointestinal surgery\n\n          -  History of alcohol or substance abuse\n\n          -  Participation in any other clinical trials within past 2 months\n\n          -  Laboratory test, medical or psychological conditions deemed by the investigators to\n             interfere with successful participation in the study\n\n          -  Pregnant or lactating women etc."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01736787", 
            "org_study_id": "HANABIO-PI-CM"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cauliflower Mushroom extract", 
                "description": "Cauliflower Mushroom extract (1g/day)", 
                "intervention_name": "Cauliflower Mushroom extract", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo (1g/day)", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cauliflower Mushroom extract", 
            "immunity"
        ], 
        "lastchanged_date": "November 26, 2012", 
        "location": {
            "contact": {
                "email": "leeh-k@jbnu.ac.kr", 
                "last_name": "Heon-Gu Lee, MD", 
                "phone": "82-63-270-3069"
            }, 
            "facility": {
                "address": {
                    "city": "Jeonju", 
                    "country": "Korea, Republic of", 
                    "state": "Jeollabuk-do", 
                    "zip": "560-822"
                }, 
                "name": "Clinical Trial Center for Functional Foods; Chonbuk National University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Cytotoxicity was measured in study visit 1(0 week) and visit 3(12 week). cytotoxicity was measured by NK cell activity. Cytotoxicity (%) = (experimental release - spontaneous release) / (maximum release - spontaneous release) x 100", 
                "measure": "Changes in Cytotoxicity", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Cytokine (IL-4, IL-10, IFN- \u03b3, TNF-\u03b1) was measured in study visit 1(0 week) and visit 3(12 week).", 
                "measure": "Changes in Cytokine (IL-4, IL-10, IFN- \u03b3, TNF-\u03b1)", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01736787"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chonbuk National University Hospital", 
            "investigator_full_name": "Soo-Wan Chae", 
            "investigator_title": "Principal Investigator, Clinical Trial Center for Functional Foods", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "CBC (WBC, RBC, Hb, Hct, MCV, MCH, MCHC, PLT) was measured in study visit 1(0 week) and visit 3(12 week).", 
            "measure": "Changes in CBC (WBC, RBC, Hb, Hct, MCV, MCH, MCHC, PLT)", 
            "safety_issue": "Yes", 
            "time_frame": "12 weeks"
        }, 
        "source": "Chonbuk National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chonbuk National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}